Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Rangering i aksjer #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Aksjekurs
$0.05137558
Sist synkronisert: 2026-08-13
Markedsverdi
$1.88M
Endring (1 dag)
0.00%
Endring (1 år)
-11.66%
Land
CA
Handel Restart Life Sciences Corp. (HEAL)

Kategori

EPS for Restart Life Sciences Corp. (HEAL)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Restart Life Sciences Corp. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Restart Life Sciences Corp. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter